In human prostate cancer cell lines (DU145 and PC3), silibinin (25–75 μg/mL) decreased the expression levels of HDAC1-2 for 48 h in a concentration-dependent manner [200]. This evidence concerns the gene HDAC1 and prostate carcinoma.